Jacobs Levy Equity Management
ADPT icon

Jacobs Levy Equity Management’s Adaptive Biotechnologies ADPT Stock Holding History

Jacobs Levy Equity Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,369
Closed -$738K – 957
2025
Q2 		$738K Sell
63,369
-53,700
-46% -$488K ﹤0.01% 815
2025
Q1 		$870K Sell
117,069
-33,002
-22% -$254K ﹤0.01% 833
2024
Q4 		$900K Buy
150,071
+6,392
+4% +$35.2K ﹤0.01% 729
2024
Q3 		$736K Buy
+143,679
New +$626K ﹤0.01% 778
2024
Q1 		– Sell
-428,858
Closed -$2.1M – 934
2023
Q4 		$2.1M Buy
+428,858
New +$1.96M 0.01% 593
2023
Q3 		– Sell
-50,930
Closed -$342K – 953
2023
Q2 		$342K Sell
50,930
-6,184
-11% -$46K ﹤0.01% 860
2023
Q1 		$504K Sell
57,114
-23,749
-29% -$209K ﹤0.01% 801
2022
Q4 		$618K Sell
80,863
-34,963
-30% -$272K ﹤0.01% 753
2022
Q3 		$825K Buy
+115,826
New +$1.09M 0.01% 743
2021
Q3 		– Sell
-14,773
Closed -$604K – 1022
2021
Q2 		$604K Buy
14,773
+4,435
+43% +$172K ﹤0.01% 829
2021
Q1 		$416K Sell
10,338
-30,227
-75% -$1.64M ﹤0.01% 887
2020
Q4 		$2.4M Sell
40,565
-897
-2% -$46.3K 0.02% 540
2020
Q3 		$2.02M Buy
41,462
+15,764
+61% +$663K 0.02% 519
2020
Q2 		$1.24M Buy
+25,698
New +$937K 0.01% 628

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management's ADPT Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 63,369 shares — an estimated $738K sold.

Jacobs Levy Equity Management first reported a position in ADPT in Q2 2020 and held it in 14 quarters. The position peaked at $2.4M in Q4 2020. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Jacobs Levy Equity Management reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 63,369 Adaptive Biotechnologies shares in Q3 2025, an estimated $738K.
  • Jacobs Levy Equity Management first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 14 quarters.
  • Jacobs Levy Equity Management's Adaptive Biotechnologies position peaked at $2.4M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.